[Abstract] [Full Text HTML] [Full Text PDF] (in Japanese / 1142KB)

J.Jpn. Surg. Soc.. 121(4): 429-434, 2020

Feature topic


Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan

Makoto Yamasaki, Tomoki Makino, Koji Tanaka, Kotaro Yamashita, Yuichiro Doki

Cervical esophageal cancer is a relatively rare disease that accounts for less than 5% of all esophageal cancer. Although cervical esophageal cancer has a high frequency of lymph node metastasis and is often diagnosed in the advanced stage, the area of lymph node metastasis is mostly limited to the neck and upper mediastinum. Under current guidelines, the standard treatment for resectable advanced cervical esophageal cancer is surgery. Since the cervical esophagus is in contact with the pharynx and larynx, it is not uncommon for the larynx to require resection. Chemoradiation is recommended when patients want to preserve the larynx, although there is no clear evidence for this. In addition, in many cases cervical esophageal cancer not only invades the hypopharynx but also the thoracic esophagus, and therefore treatment strategies such as surgical procedures, reconstruction methods, and perioperative treatment differ in each case. It is important to follow a treatment strategy that takes into account not only curability but also postoperative quality of life.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.